Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1961 1
1975 2
1976 1
1979 1
1985 1
2012 2
2013 3
2014 3
2015 13
2016 7
2017 12
2018 6
2019 6
2020 16
2021 26
2022 18
2023 10
2024 16
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: halleck f. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
eHealth in transplantation.
Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, Roller R, Mayrdorfer M, Halleck F, Schmidt D, Budde K. Duettmann W, et al. Among authors: halleck f. Transpl Int. 2021 Jan;34(1):16-26. doi: 10.1111/tri.13778. Epub 2020 Nov 27. Transpl Int. 2021. PMID: 33111393 Free article. Review.
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. Doberer K, et al. Among authors: halleck f. J Am Soc Nephrol. 2021 Mar;32(3):708-722. doi: 10.1681/ASN.2020071106. Epub 2020 Dec 18. J Am Soc Nephrol. 2021. PMID: 33443079 Free PMC article. Clinical Trial.
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.
Halleck F, Böhmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sjöholm K, Runström A, Lefèvre P, Tollemar J, Jordan S. Halleck F, et al. Clin Transplant. 2024 Jul;38(7):e15383. doi: 10.1111/ctr.15383. Clin Transplant. 2024. PMID: 39023092 Clinical Trial.
New perspectives of immunosuppression.
Halleck F, Friedersdorff F, Fuller TF, Matz M, Huber L, Dürr M, Schütz M, Budde K. Halleck F, et al. Transplant Proc. 2013 Apr;45(3):1224-31. doi: 10.1016/j.transproceed.2013.02.033. Transplant Proc. 2013. PMID: 23622665 Review.
Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies.
Cortes Garcia E, Giarraputo A, Racapé M, Goutaudier V, Ursule-Dufait C, de la Grange P, Adoux L, Raynaud M, Couderau C, Mezine F, Dagobert J, Bestard O, Moreso F, Villard J, Halleck F, Giral M, Brouard S, Danger R, Gourraud PA, Rabant M, Couzi L, Le Quintrec M, Kamar N, Morelon E, Vrtovsnik F, Taupin JL, Snanoudj R, Legendre C, Anglicheau D, Budde K, Lefaucheur C, Loupy A, Aubert O. Cortes Garcia E, et al. Among authors: halleck f. Transpl Int. 2024 Jul 10;37:13043. doi: 10.3389/ti.2024.13043. eCollection 2024. Transpl Int. 2024. PMID: 39050190 Free PMC article.
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
Goutaudier V, Danger R, Catar RA, Racapé M, Philippe A, Elias M, Raynaud M, Aubert O, Bouton D, Girardin F, Vicaut É, Yaiche S, Demotes J, Heidecke H, Taupin JL, Randoux-Lebrun C, Zaidan M, Papuchon E, Le Mai H, Nguyen TV, Moreso F, Berney T, Villard J, Legendre C, Dragun D, Papalois V, Potena L, Giral M, Gourraud PA, Brouard S, Crespo E, Halleck F, Budde K, Bestard O, Loupy A, Lefaucheur C; EU-TRAIN Consortium. Goutaudier V, et al. Among authors: halleck f. Kidney Int. 2024 Nov;106(5):943-960. doi: 10.1016/j.kint.2024.07.027. Epub 2024 Aug 27. Kidney Int. 2024. PMID: 39197587 Free article.
Office or home versus 24-h blood pressure measurement in stable kidney transplant recipients.
Eleftheriadis G, Naik MG, Osmanodja B, Halleck F, Schrezenmeier E, Liefeldt L, Choi M, Bachmann F, Avaniadi DP, von Hoerschelmann E, Lücht C, Zaks M, Duettmann W, Budde K. Eleftheriadis G, et al. Among authors: halleck f. Nephrol Dial Transplant. 2024 Oct 30;39(11):1890-1899. doi: 10.1093/ndt/gfae076. Nephrol Dial Transplant. 2024. PMID: 38549427
Risks and benefits of everolimus.
Budde K, Halleck F. Budde K, et al. Among authors: halleck f. Transpl Int. 2019 Nov;32(11):1124-1126. doi: 10.1111/tri.13489. Transpl Int. 2019. PMID: 31397931 Free article. No abstract available.
132 results